The effect of short-term aerobic training on coagulation and fibrinolytic factors in sedentary healthy postmenopausal women

OBJECTIVE: The purpose of this study was to assess the effect of short-term aerobic training on the fibrinolytic and coagulative factors in postmenopausal women.

STUDY DESIGN: Twenty volunteer sedentary healthy postmenopausal women (48-53 years), who entered the menopause naturally, were divided randomly into two groups: training (n=10) and control (n=10).

METHODS AND MAIN OUTCOME MEASURES: Training consisted of 10 sessions of submaximal aerobic cycling, 35 min for each session (5 min warm-up, 25 min aerobic training with 70% HRmax, 5 min active and 15 min passive recovery), 3 times a week. Coagulation and fibrinolytic factors were assessed both before and after aerobic program in both groups.

RESULTS: Fibrinogen, von Willbrand factor (vWF-Ag) antigen, plasminogen activator inhibitor-1 activity (PAI-1:Ac) and antigen (PAI-1:Ag) showed significant reduction after 10 sessions in the training group (P<0.05). Also after training, prothrombin time (PT), partial thromboplastin time (PTT), tissue plasminogen activator activity (tPA:Ac) and antigen (tPA:Ag) increased (P<0.05).

CONCLUSION: It was concluded that fibrinolytic activity on postmenopausal women could be improved by a 3-week regular submaximal training program. These changes on the hemostatic factors suggest that short-term aerobic training may prevent the decline in fibrinolytic function observed in sedentary postmenopausal women.

Medienart:

E-Artikel

Erscheinungsjahr:

2009

Erschienen:

2009

Enthalten in:

Zur Gesamtaufnahme - volume:64

Enthalten in:

Maturitas - 64(2009), 4 vom: 20. Dez., Seite 223-7

Sprache:

Englisch

Beteiligte Personen:

Jahangard, Tahereh [VerfasserIn]
Torkaman, Giti [VerfasserIn]
Ghoosheh, Babak [VerfasserIn]
Hedayati, Mehdi [VerfasserIn]
Dibaj, Azadeh [VerfasserIn]

Links:

Volltext

Themen:

9001-32-5
Antigens
Blood Coagulation Factors
Fibrinogen
Journal Article
Plasminogen Activator Inhibitor 1
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Von Willebrand Factor
Von Willebrand antigen

Anmerkungen:

Date Completed 30.03.2010

Date Revised 01.12.2018

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.maturitas.2009.09.003

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM192279645